# Thyme Care

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thyme-care

- Industry: Healthcare
- Headquarters: Nashville, US
- Website: www.thymecare.com
- Total disclosed funding: $339M
- Latest round: Series E (Sep 2, 2026)
- Investors on record: 15

## About

Based in Tennessee, US, and co-founded in 2020 by Robin Shah and Bobby Green, MD, Thyme Care, LLC operates as an oncology care management company that provides cancer care navigation services to cancer patients and their caregivers. Brad Diephuis, MD is the CEO of the firm. In September 2026, Thyme Care, LLC raised USD 125 million in series E funding led by Morgan Health, with participation from AlleyCorp, Andreessen Horowitz, Concord Health Partners, CVS Health Ventures, Foresite Capital, Frist Cressey Ventures, Humana Ventures, Town Hall Ventures, and HealthQuest Capital. The company provides a wide range of cancer care navigation services, such as patient support, integration with clinical teams, analytics for care quality, and cost-reduction strategies. Additionally, the firm also provides support services to oncologists and payers for better care delivery and cost management. The company generates revenue through oncology care management services, oncology navigation programs, healthcare partnerships, value-based oncology programs, healthcare technology platforms, and care coordination services provided to health plans, providers, employers, and health systems.

## Funding rounds

- Series E, Sep 2, 2026, $125M — Humana Ventures, Andreessen Horowitz, Foresite Capital, HealthQuest Capital, Frist Cressey Ventures, Town Hall Ventures, Concord Health Partners, AlleyCorp, CVS Health Ventures, Morgan Health
- Series D, Apr 4, 2025, $97M — Humana Ventures, Andreessen Horowitz, Foresite Capital, Memorial Hermann Health System Foundation, Frist Cressey Ventures, Town Hall Ventures, Concord Health Partners, AlleyCorp, CVS Health Ventures, Morgan Health, Texas Oncology
- Series C, Jul 11, 2024, $55M — Andreessen Horowitz, Foresite Capital, Frist Cressey Ventures, Echo Health Ventures, Town Hall Ventures, Concord Health Partners, AlleyCorp, CVS Health Ventures
- Series B, Jun 23, 2023, $49M — Andreessen Horowitz, Foresite Capital, Casdin Capital, Frist Cressey Ventures, Town Hall Ventures, AlleyCorp
- Series A, May 14, 2021, $14M — Bessemer Venture Partners, Andreessen Horowitz, Casdin Capital, Frist Cressey Ventures, AlleyCorp

## Investors

- Bessemer Venture Partners (https://capitalatlas.ai/funds/bessemer-venture-partners) — Series A
- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Series A, Series B, Series C, Series D, Series E
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series A, Series B
- Frist Cressey Ventures (https://capitalatlas.ai/funds/frist-cressey-ventures) — Series A, Series B, Series C, Series D, Series E
- AlleyCorp — Series A, Series B, Series C, Series D, Series E
- Foresite Capital (https://capitalatlas.ai/funds/foresite-capital) — Series B, Series C, Series D, Series E
- Town Hall Ventures (https://capitalatlas.ai/funds/town-hall-ventures) — Series B, Series C, Series D, Series E
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series C
- Concord Health Partners (https://capitalatlas.ai/funds/concord-health-partners) — Series C, Series D, Series E
- CVS Health Ventures (https://capitalatlas.ai/funds/cvs-health-ventures) — Series C, Series D, Series E
- Humana Ventures (https://capitalatlas.ai/funds/humana-ventures) — Series D, Series E
- Memorial Hermann Health System Foundation — Series D
- Morgan Health — Series D, Series E
- Texas Oncology — Series D
- HealthQuest Capital (https://capitalatlas.ai/funds/healthquest-capital) — Series E